Loading…
Transrenal Nucleic Acids: From Proof of Principle to Clinical Tests
In spite of numerous publications on potential diagnostic application of circulating DNA and transrenal nucleic acid (Tr‐NA) analysis, few, if any, tests based on this technology are available in clinical labs. This delay in test development and implementation is caused, at least in part, by the def...
Saved in:
Published in: | Annals of the New York Academy of Sciences 2008-08, Vol.1137 (1), p.73-81 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c2845-8c5c31045d420896b8c57b312b232ec36e02ede2533a1a6590f2f4bbd923c2db3 |
---|---|
cites | |
container_end_page | 81 |
container_issue | 1 |
container_start_page | 73 |
container_title | Annals of the New York Academy of Sciences |
container_volume | 1137 |
creator | Melkonyan, Hovsep S. Feaver, W. John Meyer, Erik Scheinker, Vladimir Shekhtman, Eugene M. Xin, Zhenghan Umansky, Samuil R. |
description | In spite of numerous publications on potential diagnostic application of circulating DNA and transrenal nucleic acid (Tr‐NA) analysis, few, if any, tests based on this technology are available in clinical labs. This delay in test development and implementation is caused, at least in part, by the deficit in robust methods for isolation of short nucleic acid fragments from bodily fluids, as well as in techniques for analyzing these fragments. We have developed a new anion exchanger‐based method for the isolation of cell‐free nucleic acid fragments from large volumes of bodily fluids, and analyzed these fragments by PCR techniques specially designed to amplify “ultrashort” templates. The combination of these two techniques not only revealed the presence in urine of 10–150 bases or bp DNA and RNA fragments in addition to previously observed 150–200‐bp DNA fragments and high molecular weight DNA, but also significantly increased the sensitivity of Tr‐DNA detection. Additionally, we detected in urine a variety of miRNAs, including those excreted transrenally, thereby opening new diagnostic possibilities for Tr‐NA analysis. |
doi_str_mv | 10.1196/annals.1448.015 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_69638688</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69638688</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2845-8c5c31045d420896b8c57b312b232ec36e02ede2533a1a6590f2f4bbd923c2db3</originalsourceid><addsrcrecordid>eNqFkM1LwzAYh4Mobk7P3qQnb535apJ6G8VNYc7BpqKXkKYpRLt2Jiu6_96MTj0KgYTk-b1v3geAcwSHCKXsStW1qvwQUSqGECUHoI84TWPGCD4EfQg5j0WKSQ-ceP8GIcKC8mPQQ0IQnmLRB9nSqdo7E8pEs1ZXxupopG3hr6Oxa1bR3DVNGYU1d7bWdl2ZaNNEWWVrq0NkafzGn4KjMvzCnO33AXgc3yyz23j6MLnLRtNYh7ZJLHSiCYI0KSiGImV5uOA5QTjHBBtNmIHYFAYnhCikWJLCEpc0z4swgMZFTgbgsqu7ds1HGzrLlfXaVJWqTdN6yVJGBAuj_QdihCmDDAXwYg-2-coUcu3sSrmt_PETANEBn7Yy2793KHf6Zadf7vTLoF_OXkYLhAgP5xCNu6j1G_P1G1XuXTJOeCKfZxPJXvFizvi9fCLfIDqHCg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>21246061</pqid></control><display><type>article</type><title>Transrenal Nucleic Acids: From Proof of Principle to Clinical Tests</title><source>Wiley</source><creator>Melkonyan, Hovsep S. ; Feaver, W. John ; Meyer, Erik ; Scheinker, Vladimir ; Shekhtman, Eugene M. ; Xin, Zhenghan ; Umansky, Samuil R.</creator><creatorcontrib>Melkonyan, Hovsep S. ; Feaver, W. John ; Meyer, Erik ; Scheinker, Vladimir ; Shekhtman, Eugene M. ; Xin, Zhenghan ; Umansky, Samuil R.</creatorcontrib><description>In spite of numerous publications on potential diagnostic application of circulating DNA and transrenal nucleic acid (Tr‐NA) analysis, few, if any, tests based on this technology are available in clinical labs. This delay in test development and implementation is caused, at least in part, by the deficit in robust methods for isolation of short nucleic acid fragments from bodily fluids, as well as in techniques for analyzing these fragments. We have developed a new anion exchanger‐based method for the isolation of cell‐free nucleic acid fragments from large volumes of bodily fluids, and analyzed these fragments by PCR techniques specially designed to amplify “ultrashort” templates. The combination of these two techniques not only revealed the presence in urine of 10–150 bases or bp DNA and RNA fragments in addition to previously observed 150–200‐bp DNA fragments and high molecular weight DNA, but also significantly increased the sensitivity of Tr‐DNA detection. Additionally, we detected in urine a variety of miRNAs, including those excreted transrenally, thereby opening new diagnostic possibilities for Tr‐NA analysis.</description><identifier>ISSN: 0077-8923</identifier><identifier>EISSN: 1749-6632</identifier><identifier>EISSN: 1930-6547</identifier><identifier>DOI: 10.1196/annals.1448.015</identifier><identifier>PMID: 18837928</identifier><language>eng</language><publisher>Malden, USA: Blackwell Publishing Inc</publisher><subject>amplification target size ; Base Sequence ; Body Fluids - chemistry ; Diagnostic Techniques and Procedures ; DNA - blood ; DNA - chemistry ; DNA - genetics ; DNA - urine ; DNA purification ; Female ; Humans ; Kidney - metabolism ; Male ; MicroRNAs - genetics ; MicroRNAs - urine ; miRNA ; Molecular Weight ; PCR ; Prokaryotic Cells ; RNA purification ; Templates, Genetic ; Tr-DNA ; Tr-RNA ; transrenal DNA ; transrenal RNA ; urine</subject><ispartof>Annals of the New York Academy of Sciences, 2008-08, Vol.1137 (1), p.73-81</ispartof><rights>2008 New York Academy of Sciences</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2845-8c5c31045d420896b8c57b312b232ec36e02ede2533a1a6590f2f4bbd923c2db3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18837928$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Melkonyan, Hovsep S.</creatorcontrib><creatorcontrib>Feaver, W. John</creatorcontrib><creatorcontrib>Meyer, Erik</creatorcontrib><creatorcontrib>Scheinker, Vladimir</creatorcontrib><creatorcontrib>Shekhtman, Eugene M.</creatorcontrib><creatorcontrib>Xin, Zhenghan</creatorcontrib><creatorcontrib>Umansky, Samuil R.</creatorcontrib><title>Transrenal Nucleic Acids: From Proof of Principle to Clinical Tests</title><title>Annals of the New York Academy of Sciences</title><addtitle>Ann N Y Acad Sci</addtitle><description>In spite of numerous publications on potential diagnostic application of circulating DNA and transrenal nucleic acid (Tr‐NA) analysis, few, if any, tests based on this technology are available in clinical labs. This delay in test development and implementation is caused, at least in part, by the deficit in robust methods for isolation of short nucleic acid fragments from bodily fluids, as well as in techniques for analyzing these fragments. We have developed a new anion exchanger‐based method for the isolation of cell‐free nucleic acid fragments from large volumes of bodily fluids, and analyzed these fragments by PCR techniques specially designed to amplify “ultrashort” templates. The combination of these two techniques not only revealed the presence in urine of 10–150 bases or bp DNA and RNA fragments in addition to previously observed 150–200‐bp DNA fragments and high molecular weight DNA, but also significantly increased the sensitivity of Tr‐DNA detection. Additionally, we detected in urine a variety of miRNAs, including those excreted transrenally, thereby opening new diagnostic possibilities for Tr‐NA analysis.</description><subject>amplification target size</subject><subject>Base Sequence</subject><subject>Body Fluids - chemistry</subject><subject>Diagnostic Techniques and Procedures</subject><subject>DNA - blood</subject><subject>DNA - chemistry</subject><subject>DNA - genetics</subject><subject>DNA - urine</subject><subject>DNA purification</subject><subject>Female</subject><subject>Humans</subject><subject>Kidney - metabolism</subject><subject>Male</subject><subject>MicroRNAs - genetics</subject><subject>MicroRNAs - urine</subject><subject>miRNA</subject><subject>Molecular Weight</subject><subject>PCR</subject><subject>Prokaryotic Cells</subject><subject>RNA purification</subject><subject>Templates, Genetic</subject><subject>Tr-DNA</subject><subject>Tr-RNA</subject><subject>transrenal DNA</subject><subject>transrenal RNA</subject><subject>urine</subject><issn>0077-8923</issn><issn>1749-6632</issn><issn>1930-6547</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNqFkM1LwzAYh4Mobk7P3qQnb535apJ6G8VNYc7BpqKXkKYpRLt2Jiu6_96MTj0KgYTk-b1v3geAcwSHCKXsStW1qvwQUSqGECUHoI84TWPGCD4EfQg5j0WKSQ-ceP8GIcKC8mPQQ0IQnmLRB9nSqdo7E8pEs1ZXxupopG3hr6Oxa1bR3DVNGYU1d7bWdl2ZaNNEWWVrq0NkafzGn4KjMvzCnO33AXgc3yyz23j6MLnLRtNYh7ZJLHSiCYI0KSiGImV5uOA5QTjHBBtNmIHYFAYnhCikWJLCEpc0z4swgMZFTgbgsqu7ds1HGzrLlfXaVJWqTdN6yVJGBAuj_QdihCmDDAXwYg-2-coUcu3sSrmt_PETANEBn7Yy2793KHf6Zadf7vTLoF_OXkYLhAgP5xCNu6j1G_P1G1XuXTJOeCKfZxPJXvFizvi9fCLfIDqHCg</recordid><startdate>200808</startdate><enddate>200808</enddate><creator>Melkonyan, Hovsep S.</creator><creator>Feaver, W. John</creator><creator>Meyer, Erik</creator><creator>Scheinker, Vladimir</creator><creator>Shekhtman, Eugene M.</creator><creator>Xin, Zhenghan</creator><creator>Umansky, Samuil R.</creator><general>Blackwell Publishing Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7TM</scope><scope>7X8</scope></search><sort><creationdate>200808</creationdate><title>Transrenal Nucleic Acids: From Proof of Principle to Clinical Tests</title><author>Melkonyan, Hovsep S. ; Feaver, W. John ; Meyer, Erik ; Scheinker, Vladimir ; Shekhtman, Eugene M. ; Xin, Zhenghan ; Umansky, Samuil R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2845-8c5c31045d420896b8c57b312b232ec36e02ede2533a1a6590f2f4bbd923c2db3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>amplification target size</topic><topic>Base Sequence</topic><topic>Body Fluids - chemistry</topic><topic>Diagnostic Techniques and Procedures</topic><topic>DNA - blood</topic><topic>DNA - chemistry</topic><topic>DNA - genetics</topic><topic>DNA - urine</topic><topic>DNA purification</topic><topic>Female</topic><topic>Humans</topic><topic>Kidney - metabolism</topic><topic>Male</topic><topic>MicroRNAs - genetics</topic><topic>MicroRNAs - urine</topic><topic>miRNA</topic><topic>Molecular Weight</topic><topic>PCR</topic><topic>Prokaryotic Cells</topic><topic>RNA purification</topic><topic>Templates, Genetic</topic><topic>Tr-DNA</topic><topic>Tr-RNA</topic><topic>transrenal DNA</topic><topic>transrenal RNA</topic><topic>urine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Melkonyan, Hovsep S.</creatorcontrib><creatorcontrib>Feaver, W. John</creatorcontrib><creatorcontrib>Meyer, Erik</creatorcontrib><creatorcontrib>Scheinker, Vladimir</creatorcontrib><creatorcontrib>Shekhtman, Eugene M.</creatorcontrib><creatorcontrib>Xin, Zhenghan</creatorcontrib><creatorcontrib>Umansky, Samuil R.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Nucleic Acids Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of the New York Academy of Sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Melkonyan, Hovsep S.</au><au>Feaver, W. John</au><au>Meyer, Erik</au><au>Scheinker, Vladimir</au><au>Shekhtman, Eugene M.</au><au>Xin, Zhenghan</au><au>Umansky, Samuil R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transrenal Nucleic Acids: From Proof of Principle to Clinical Tests</atitle><jtitle>Annals of the New York Academy of Sciences</jtitle><addtitle>Ann N Y Acad Sci</addtitle><date>2008-08</date><risdate>2008</risdate><volume>1137</volume><issue>1</issue><spage>73</spage><epage>81</epage><pages>73-81</pages><issn>0077-8923</issn><eissn>1749-6632</eissn><eissn>1930-6547</eissn><abstract>In spite of numerous publications on potential diagnostic application of circulating DNA and transrenal nucleic acid (Tr‐NA) analysis, few, if any, tests based on this technology are available in clinical labs. This delay in test development and implementation is caused, at least in part, by the deficit in robust methods for isolation of short nucleic acid fragments from bodily fluids, as well as in techniques for analyzing these fragments. We have developed a new anion exchanger‐based method for the isolation of cell‐free nucleic acid fragments from large volumes of bodily fluids, and analyzed these fragments by PCR techniques specially designed to amplify “ultrashort” templates. The combination of these two techniques not only revealed the presence in urine of 10–150 bases or bp DNA and RNA fragments in addition to previously observed 150–200‐bp DNA fragments and high molecular weight DNA, but also significantly increased the sensitivity of Tr‐DNA detection. Additionally, we detected in urine a variety of miRNAs, including those excreted transrenally, thereby opening new diagnostic possibilities for Tr‐NA analysis.</abstract><cop>Malden, USA</cop><pub>Blackwell Publishing Inc</pub><pmid>18837928</pmid><doi>10.1196/annals.1448.015</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0077-8923 |
ispartof | Annals of the New York Academy of Sciences, 2008-08, Vol.1137 (1), p.73-81 |
issn | 0077-8923 1749-6632 1930-6547 |
language | eng |
recordid | cdi_proquest_miscellaneous_69638688 |
source | Wiley |
subjects | amplification target size Base Sequence Body Fluids - chemistry Diagnostic Techniques and Procedures DNA - blood DNA - chemistry DNA - genetics DNA - urine DNA purification Female Humans Kidney - metabolism Male MicroRNAs - genetics MicroRNAs - urine miRNA Molecular Weight PCR Prokaryotic Cells RNA purification Templates, Genetic Tr-DNA Tr-RNA transrenal DNA transrenal RNA urine |
title | Transrenal Nucleic Acids: From Proof of Principle to Clinical Tests |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T14%3A10%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transrenal%20Nucleic%20Acids:%20From%20Proof%20of%20Principle%20to%20Clinical%20Tests&rft.jtitle=Annals%20of%20the%20New%20York%20Academy%20of%20Sciences&rft.au=Melkonyan,%20Hovsep%20S.&rft.date=2008-08&rft.volume=1137&rft.issue=1&rft.spage=73&rft.epage=81&rft.pages=73-81&rft.issn=0077-8923&rft.eissn=1749-6632&rft_id=info:doi/10.1196/annals.1448.015&rft_dat=%3Cproquest_pubme%3E69638688%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2845-8c5c31045d420896b8c57b312b232ec36e02ede2533a1a6590f2f4bbd923c2db3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=21246061&rft_id=info:pmid/18837928&rfr_iscdi=true |